View Post

Hexavalent Lyme Disease Vaccine Elicited Antibody Responses to OspA Serotypes

In COVID-19, Latest News by Precision Vaccinations

Lyme disease is recognized as the most common vector-borne illness in the Northern Hemisphere, but its actual incidence rate is unknown. It is estimated that over 400,000 people in the U.S. and 129,000 in Europe are diagnosed and treated for Lyme disease each year.
While the disease can be treated, many outdoor enthusiasts eagerly await a preventive vaccine's approval.